BRD4 inhibition promotes TRAIL-induced apoptosis by suppressing the transcriptional activity of NF-κB in NSCLCBRD4 inhibition promotes TRAIL-induced apoptosis by suppressing the transcriptional activity of NF-κB in NSCLC
Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) and agonistic antibodies in opposition to TRAIL dying receptors (DR) can induce apoptosis preferentially in tumor cells whereas inflicting just about no harm to regular
